Journal of diabetes and its complicationsHumansThioctic AcidDiabetes MellitusType 1Diabetic Nephropathies
The role of oral alpha-lipoic acid as an adjuvant antioxidant therapy in diabetic nephropathy among children and adolescents with type 1 diabetes: a randomized controlled trial.
Yasmine Ibrahim Elhenawy, Rasha Adel Thabet, Marwa G A Hegazy, Shymaa Ayed El-Morsy, Yasmeen AbdelAziz Fereig
Published: 202610.1016/j.jdiacomp.2025.109201
Abstract
AIM: Evaluate the oxidant-antioxidant balance and the efficacy of Alpha-lipoic acid (ALA) as an adjuvant therapy for diabetic nephropathy (DN) among individuals with type 1 diabetes (T1D). MATERIALS AND METHODS: A 3 months prospective randomized cont…
Preview only. Read the full abstract at the source